Children born small for gestational age (SGA), defined as a birth weight and/or length
below− 2 SD score (SDS), comprise a heterogeneous group. The causes of SGA are …

Abstract This International Consensus Guideline was developed by experts in the field of
small for gestational age (SGA) of 10 pediatric endocrine societies worldwide. A consensus …

The goal of growth hormone (GH) treatment in a short child is to attain a fast catch-up growth
toward the target height (TH) standard deviation score (SDS), followed by a maintenance …

Background: The reason for the insufficient catch-up growth seen in 10% of children born
small for gestational age (SGA) is poorly understood. Disturbances in the growth hormone …

The use of growth hormone (GH) to treat children who have disturbances of growth is
complicated by variability both within and across diagnostic groups, and at the start of and …

Abstract Treatment with growth hormone (GH) has become standard practice for
replacement in GH-deficient children or pharmacotherapy in a variety of disorders with short …

Context: Weight-based GH dosing results in a wide variation in growth response in children
with GH deficiency (GHD) or idiopathic short stature (ISS). Objective: The hypothesis tested …

Abstract Background/Aims: There is limited information about adult height (AH) outcomes
and the factors influencing outcomes of growth hormone (GH) therapy in short children born …

It is over sixty years since the first administration of human growth hormone (GH) to children
with GH deficiency, and over thirty years since recombinant human GH has been available …

Growth and development are important and sensitive parameters of health and disease. The
most important measure of growth is body length. Several factors influence postnatal growth …